Latest Rosetta Genomics Stories
NEW YORK, July 15 /PRNewswire-FirstCall/ -- Rosetta Genomics (Nasdaq: ROSG) announces the following Webcast: What: LHA Life Sciences & Med Tech Day 2010 Presentation When: July 20, 2010 @ 9:30 AM Eastern http://www.investorcalendar.com/ Where: ClientPage.asp?ID=160317 Live over the Internet --Simply log on to the web at How: the address above. Contact: Cheryl Palazzo, 212-838-3777, email@example.com...
Virginia Commonwealth University researchers have discovered a mechanism by which an enzyme regulates gene expression and growth in melanoma cells, a finding that could someday lead to more effective drugs to attack cancers and make them more treatable.
FREMONT, Calif., June 17 /PRNewswire-FirstCall/ -- WaferGen Biosystems, Inc.
FREMONT, Calif., June 10 /PRNewswire-FirstCall/ -- WaferGen Biosystems, Inc.
FREMONT, Calif., March 16 /PRNewswire-FirstCall/ -- WaferGen Biosystems, Inc.
FREMONT, Calif., Dec. 16 /PRNewswire-FirstCall/ -- WaferGen Biosystems, Inc.
CARLSBAD, Calif., Dec. 9 /PRNewswire/ -- Regulus Therapeutics Inc. will host an educational Webinar featuring a discussion with leading microRNA scientists: Tom Tuschl, Ph.D. Professor at Rockefeller University and Markus Stoffel, M.D., Ph.D. Professor at the Swiss Federal Institute of Technology.
SAN DIEGO, Oct. 15 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the nationwide commercial launch of three new cancer diagnostic products: ProOnc TumorSource Dx, ProOnc Squamous Dx and ProOnc Mesothelioma Dx.
Researchers continue to add to the diagnostic alphabet of saliva by identifying the presence of at least 50 microRNAs that could aid in the detection of oral cancer, according to a report in Clinical Cancer Research, a journal of the American Association for Cancer Research.
New Product Names for Recently Introduced MicroRNA-based Diagnostics Also Unveiled SAN DIEGO, June 1 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, presented an overview of its proprietary oncology diagnostic platform yesterday at the American Society of Clinical Oncology (ASCO) Annual Meeting in Orlando. In a presentation entitled "Profiling of Receptor Tyrosine Kinases (RTK) Activation in Circulating Tumor Cells (CTCs) in Metastatic Tumors...
- A small wooded valley; a dell.
- The protecting weather-shed built around the entrance to a house.